Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Probiotics and Healthy Eating for Overweight Adolescents During COVID-19

Official title: Dietary Modulation of Gut Microbiota on Nutritional Status and COVID-19 Infection in Adolescents: Gut-Lung-Axis

Run by Universitas Indonesia · NCT05623007 · Data updated 2026-11-12

This study is testing if giving probiotics and healthy eating advice can help overweight teens who have had the COVID-19 vaccine feel better and improve their health.

More Child Development trials

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment440 (estimated)
SponsorUniversitas Indonesia
Academic / other
Locations1 site (Jakarta Pusat, DKI Jakarta)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedApril 30, 2025
Study endsDecember 30, 2025
Registry record updatedFebruary 25, 2025
Trial IDNCT05623007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adolescents aged 12-17 years, living in Jakarta, Surabaya, or Yogyakarta, who are overweight or obese and have completed at least two doses of the CoronaVac® vaccine.

Probably not a fit

Patients with a recent history of COVID-19 infection, chronic diseases, or gastrointestinal disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of probiotic supplementation and counseling on healthy eating and physical activity in overweight and obese adolescents aged 12-17 years who have received at least two doses of the CoronaVac® COVID-19 vaccine. The aim is to assess whether these interventions can improve gut microbiota, enhance immune response to SARS-CoV-2, and promote better health outcomes. Participants will be randomly assigned to receive either probiotics or placebo, alongside lifestyle counseling. The study is conducted in urban areas of Indonesia, focusing on the relationship between nutrition, infection, and immune health during adolescence.

Why it matters

Potential benefit: If successful, this study could provide a novel approach to improving health and immune response in overweight adolescents, potentially reducing their risk of severe COVID-19 outcomes.

How similar studies have gone: While there is limited evidence specifically addressing probiotics in this context, previous studies have shown potential benefits of probiotics in improving health outcomes in overweight adolescents.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. living in Jakarta, Surabaya, and Yogyakarta City for at least 6 months permanently;
2. apparently healthy;
3. male and female, age 12-17 years old;
4. overweight or obese (BMI-for-age z-score \>+1SD);
5. have completed at least two dosages of COVID-19 vaccine, the vaccine must be CoronaVac® (Sinovac);
6. minimal 6 months post vaccinated prior to recruitments.
7. parents willing to sign the informed consent and adolescents give informed assent;
8. Must have an active health insurance, for instance BPJS or similar health insurance.

Exclusion Criteria:

1. having a history of COVID-19 infection within the last month confirmed by PCR or antigen from health care facilities or independent laboratory;
2. having a history of chronic and non-communicable diseases, congenital diseases, and disabilities;
3. reported current diagnosed as suspected active Tuberculosis (primary lung TB, miliary TB, bleeding cough bone TB, meningitis TB);
4. having a history of gastrointestinal or malabsorption disorder (such as celiac disease and inflammatory bowel disease) within the last three months or during the study;
5. taking antibiotics during 2 weeks before the start of the study (adolescents will be included after 3 weeks of last antibiotic intake);
6. taking other medications or having diseases that may influence the immune response - i.e. immune deficiencies, immunosuppressants medications, blood transfusion or other blood products;
7. taking insulin and/or anti-dyslipidemia medication;
8. being pregnant and/or breastfeeding.

Where it's running

  • Department of Nutrition (FKUI-RSCM); and Human Nutrition Research Center, Indonesian Medical Education Research Institute (HNRC-IMERI) Faculty of Medicine, Universitas Indonesia
    Jakarta Pusat, DKI Jakarta, Indonesia
    Recruiting

Study contacts

  • Principal investigator: Rina Agustina, PhD — Dep of Nutrition and Human Nutrition Research Center, IMERI, Fac of Medicine Universitas Indonesia
  • Study coordinator: Rina Agustina, PhD
  • Email: dr.rinaagustina@gmail.com
  • Phone: +622129189160

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.